ITM Isotopen Technologien München AG

Biotechnology, Chemical Industry, Medical Technology

  • Short facts

  • Year founded 2004
  • 210 Employees (site)
  • Turnover: not available

Products/services: ITM Isotopen Technologien München AG is a privately held biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for use in cancer treatment. ITM’s main objectives, together with its scientific, medical and industrial collaboration partners worldwide, are to significantly improve outcomes and quality of life for cancer patients while at the same time reducing side effects and improving health economics through a new generation of Targeted Radionuclide Therapies in Precision Oncology.

Basic data

Company

ITM Isotopen Technologien München AG

Street

Lichtenbergstr. 1

PC / City

85748 Garching

County

Upper Bavaria

Phone

+49 89 329 8986 600

Fax

+49 89 329 8986 650

Email

Language skills

English, German

Contact person

Management: Steffen Schuster (Mr.)

Profile/competences

Core competencies

Since its foundation in 2004, ITM and its subsidiaries have established GMP manufacturing and a robust global supply network of innovative, first-in-class medical radionuclides and generator platforms for a new generation of targeted cancer diagnostics and therapies. Furthermore, ITM is developing a proprietary portfolio and growing pipeline of targeted treatments in various stages of clinical development, which address a range of cancers such as neuroendocrine tumors and bone metastases.

Key sectors / sub-sectors

  • Biotechnology: Biotechnological reagents
  • Chemical Industry: Inorganic basic chemicals
  • Chemical Industry: Pharmaceutical basic products
  • Medical Technology: Cancer diagnostics and therapy
  • Medical Technology: Nuclear medicine

NACE industries

  • Manufacture of chemicals and chemical products 20
  • Manufacture of basic pharmaceutical products and pharmaceutical preparations 21
  • Scientific research and development 72

Certifications

  • GMP

Sales markets - target industries

global

Sales markets - target countries

not available

Cooperation offers

not available